FAIZ MANSOUR: Open Payments
NPI 1508974999 · BLOOMFIELD HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 70 payments from 14 companies in 2025. Trend: 2023 $1,139 · 2024 $1,023 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $355 |
| Novo Nordisk Inc | 20 | $340 |
| GlaxoSmithKline, LLC. | 6 | $106 |
| Lilly USA, LLC | 5 | $88 |
| PFIZER INC. | 4 | $77 |
| Abbott Laboratories | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Amgen Inc. | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
Products named: AIRSUPRA, Rybelsus, Ozempic, TRELEGY ELLIPTA, ELIQUIS, MOUNJARO, Wegovy, FREESTYLE LIBRE 3.
Industry payments across MI — which companies pay providers there.
